Development and evaluation of albumin binder-conjugated heterodimeric radiopharmaceuticals targeting integrin α v β 3 and CD13 for cancer therapy.
Biao YangChangyu ShanXiangming SongXiaoying LvYu LongDexing ZengRui AnXiaoli LanYongkang GaiPublished in: European journal of nuclear medicine and molecular imaging (2024)
Lu.